Dysregulation of Wnt signaling in cancer can occur through various mechanisms:
Mutations in APC, β-catenin, or other components Overexpression of Wnt ligands or receptors Epigenetic modifications Cross-talk with other signaling pathways
These alterations can lead to the accumulation of β-catenin in the nucleus, driving the expression of genes involved in cell cycle progression and survival.
